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Wiskott-Aldrich syndrome (WAS) is an X-linked 
immunodeficiency characterized by recurrent 
infections, abnormal lymphocyte function, throm-
bocytopenia, and eczema, as well as a signifi-
cantly increased risk for systemic autoimmunity 
(Sullivan et al., 1994). The affected gene, WAS 
protein (WASp), encodes a multidomain protein, 
WASp, which is exclusively expressed in hemato-
poietic cells, where it is involved in signal trans-
duction  to  the  actin  cytoskeleton  (Thrasher 
2002). Signaling defects resulting from WASp 
deficiency have been analyzed most exten-
sively in T lymphocytes. After TCR ligation, 
WASp/ T cells show decreased Ca2+ flux, re-
duced actin polymerization, diminished anti-
gen receptor (AR) endocytosis, and abnormal 
proliferation caused by deficient IL-2 secretion 
(Bouma et al., 2009). WASp deficiency impacts 
additional lineages, including B cells, NKT cells, 
neutrophils,  DCs,  monocytes,  and  platelets. 
These defects may contribute independently or 
in combination to mediate the complex clinical 
features of WAS.
The functional defect that promotes auto-
immunity in WAS is of great interest. Preva-
lence of autoimmune symptoms in WAS is high; 
in one study >70% of patients had at least one   
autoimmune episode, including autoimmune 
cytopenias, arthritis, vasculitis, or renal disease, 
and many of these patients suffered from recur-
rent or multiple autoimmune features (Sullivan   
et al., 1994; Dupuis-Girod et al., 2003). Auto-
immunity typically presents early in life, is often 
refractory to therapy, and is associated with a 
worse clinical prognosis (Imai et al., 2004). 
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Patients with the immunodeficiency Wiskott-Aldrich syndrome (WAS) frequently develop 
systemic autoimmunity. Here, we demonstrate that mutation of the WAS gene results in  
B cells that are hyperresponsive to B cell receptor and Toll-like receptor (TLR) signals in vitro, 
thereby promoting a B cell–intrinsic break in tolerance. Whereas this defect leads to auto-
antibody production in WAS protein–deficient (WASp/) mice without overt disease, 
chimeric mice in which only the B cell lineage lacks WASp exhibit severe autoimmunity 
characterized by spontaneous germinal center formation, class-switched autoantibodies, 
renal histopathology, and early mortality. Both T cell help and B cell–intrinsic TLR engage-
ment play important roles in promoting disease in this model, as depletion with anti-CD4 
antibodies or generation of chimeric mice with B cells deficient in both WASp and MyD88 
prevented development of autoimmune disease. These data highlight the potentially harm-
ful role for cell-intrinsic loss of B cell tolerance in the setting of normal T cell function, 
and may explain why WAS patients with mixed chimerism after stem cell transplantation 
often develop severe humoral autoimmunity.
© 2011 Becker-Herman et al.  This article is distributed under the terms of an 
Attribution–Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first   
six months after the publication date (see http://www.rupress.org/terms). After   
six  months  it  is  available  under  a  Creative  Commons  License  (Attribution– 
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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WASp/ B cells are sufficient for high-affinity,  
class-switched autoantibody production
We next sought to determine if autoantibody production in 
WASp/ mice is a B cell–intrinsic phenomenon using a 
mixed  BM  chimera  model.  Of  the  multiple  strategies  we 
tested, optimal B cell reconstitution with minimal mixed chi-
merism  in  other  hematopoietic  lineages  was  achieved  by 
transplanting a mix of 20% WASp/ or WT BM with 80% 
MT BM into lethally (1050 cGy) irradiated MT recipi-
ents. To eliminate transfer of previously activated B cell popu-
lations, we used BM from very young donors (4–5 wk) 
depleted of plasma B cells. Donor sera were also prescreened 
to verify absence of dsDNA antibodies. After reconstitution, 
B cells were entirely donor derived (WASp/ or WT), >95% 
of CD3+ T cells and CD4+ Foxp3+ T reg cells were WASp+, 
and  >85%  of  both  NK  and  myeloid  cells  were WASp+  
(Fig. S1 B). Consistent with a B cell–intrinsic role for WASp, 
recipients  of  WASp/  BM  cells  (hereafter  referred  to  as 
WASp/ chimeras) developed high titers of anti-dsDNA 
autoantibodies, whereas WT recipients did not (Fig. 1 B). A pro-
portion of WASp/ chimeras did not have high anti-dsDNA 
antibody titers at 16 wk after transplant, but this proportion 
decreased when mice were analyzed at later time points (un-
published data), suggesting that WASp/ chimeras experi-
ence a progressive loss in B cell tolerance as they age. Because 
WASp/ T cells are functionally abnormal, we predicted that 
the presence of WT T cells in WASp/ chimeras may drive 
more efficient germinal center (GC) responses, resulting in 
class switch recombination (CSR) and affinity maturation.   
To test this idea, we evaluated anti-dsDNA autoantibody af-
finity using high and low stringency ELISA washing con-
ditions. Anti-dsDNA  autoantibodies  were  detected  after 
high-stringency washing in WASp/ chimeras as early as 12 wk 
after transplant, compared with a lack of consistent high-titer 
anti-dsDNA autoantibody production in 12 wk old WASp/ 
mice (Fig. 1 C). Next, we analyzed the subclass of anti- 
dsDNA autoantibodies. Strikingly, WASp/ mice generated 
primarily IgG3 autoantibodies, whereas WASp/ chimeras 
generated IgG2b and IgG2c, but little or no IgG3, anti- 
dsDNA autoantibodies (Fig. 1, D–F). Consistent with our   
hypothesis that WT T cells drive GC formation in WASp/ 
chimeras, we found greater numbers of B220+PNA+ spleno-
cytes in WASp/ compared with WT chimeras (Fig. 1 G). 
Additionally, histological analysis of splenic sections revealed 
consistently larger and more frequent PNA+ GCs in WASp/ 
versus WT chimeras (Fig. 1 H). Widespread spontaneous GC 
formation, as detected in WASp/ chimeras, is a character-
istic  feature  of  several  previously  described  autoimmune- 
susceptible mouse strains (Luzina et al., 2001).
To  determine  whether  other  autoantibody  specificities 
produced by WASp/ mice are recapitulated in WASp/ 
chimeras, custom microarray slides were prepared with vari-
ous DNA-associated antigens and apoptotic cell epitopes and 
screened using sera from WT, WASp/, WT chimera, and 
WASp/ chimera mice. IgG antibody reactivity to chromatin, 
dsDNA, ssDNA, and the apoptosis associated neo-determinant 
Consistent with these observations in patients, WASp/ 
mice develop high-titer, anti–double-stranded (ds) DNA anti-
bodies early in life (Humblet-Baron et al., 2007). However, 
only minimal autoantibody-mediated disease features have been 
reported in this strain (Humblet-Baron et al., 2007; Nikolov et al., 
2010), suggesting such antibodies are relatively nonpathogenic.
Interestingly,  a  significant  proportion  of WAS  patients 
treated using stem cell transplantation develop systemic auto-
immunity that is not predicted by pretransplant disease fea-
tures  (Ozsahin  et  al.,  2008). This  complication  is  strongly 
associated with mixed/split chimerism, indicating that resid-
ual WAS mutant lymphocytes can mediate autoimmune dis-
ease despite the coexistence of normal donor cells. These data 
imply that, in a chimeric setting, dysregulated function within 
a candidate lymphoid population is unmasked by restoration 
of functional activity within other hematopoietic lineages.
Notably, several recent studies including work from our 
laboratory  demonstrated  defects  in  both  homeostasis  and 
function of WASp/ regulatory T cells (T reg cells). These 
observations suggested that altered T reg cell activity might 
predispose  to  autoantibody  production  in  WASp/  mice 
(Humblet-Baron et al., 2007; Maillard et al., 2007; Marangoni 
et al., 2007). In the current study, we made the surprising ob-
servation that female WASp+/ mice generate anti–nuclear 
antibodies at rates and titers equivalent to WASp/ mice, 
even though carrier animals have an essentially normal T reg 
cell compartment because of a strong selective advantage for 
WASp+ T reg cells. Based on this observation, we tested the al-
ternative hypothesis that autoantibody production in WASp/ 
mice results from a B cell–intrinsic defect. Consistent with 
this idea, we show that in the setting of WT T cells, DCs, and 
other hematopoietic lineages, WASp/ B cells are necessary 
and sufficient for development of autoantibodies. Collectively, 
our results suggest that B cell receptor (BCR)/Toll-like re-
ceptor (TLR) co-engagement on WASp/ B cells mediates 
loss of tolerance, which, in the presence of WT T cells, drives 
development of severe autoimmune disease.
RESULTS
WASp+/ carrier females develop high-titer  
anti-dsDNA antibodies
We previously reported that WASp is essential for normal   
T reg cell homeostasis (Humblet-Baron et al., 2007), leading 
to the hypothesis that autoantibody production in WASp/ 
mice results from a lack of T reg cell–mediated immunosup-
pression. To address this idea, we analyzed WASp+/ female 
mice in which >90% of peripheral T reg cells are WASp+  
because of a selective advantage over T reg cells expressing the 
mutated X-linked WASp allele (Humblet-Baron et al., 2007). 
Surprisingly, we found no difference in the amount of anti-
dsDNA  autoantibodies  between  WASp/  and  WASp+/ 
mice (Fig. 1 A). T reg cells isolated from WASp+/ mice were 
functionally indistinguishable from WT T reg cells in sup-
pressing T cell proliferation (Fig. S1 A). Collectively, these data 
imply that impaired T reg cell function is unlikely to explain 
the development of autoantibodies in WASp/ mice.JEM Vol. 208, No. 10 
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antigen–specific  autoantibodies  in  the  presence  of WT- 
derived hematopoietic cells.
WASp/ chimeras develop systemic autoimmunity  
and exhibit early mortality
Despite the presence of high-titer anti-dsDNA autoanti-
bodies, WASp/ mice on a C57BL/6 background do not de-
velop systemic autoimmune features or increased mortality 
(unpublished data). To assess the longer-term consequences   
of  B  cell-specific WASp-deficiency,  cohorts  of  WASp/  
versus WT chimeras were followed for >1 yr. Strikingly, 
WASp/ chimeras exhibited increased mortality beginning 
malondialdehyde (MDA) as a conjugate with low-density lipo-
protein (MDA-LDL), was detected in both WASp/ and 
WASp/ chimera sera, but not in WT mice or WT chimeras 
(Fig. 1 I). ELISAs confirmed the presence of anti–MDA-LDL 
antibodies in WASp/ mice and chimeras, and further sub-
class analysis revealed that, in a similar pattern to anti-dsDNA 
antibodies, WASp/ mice produced primarily IgG3 anti-
bodies,  whereas  WASp/  chimeras  produced  IgG2b  and 
IgG2c anti–MDA-LDL antibodies (Fig. S2).
These  combined  experiments  support  the  conclusion 
that WASp deficiency in B cells is sufficient for develop-
ment  of  high-affinity,  class-switched  DNA  and  apoptotic 
Figure 1.  WASp/ B cells are sufficient for high-affinity, class-switched autoantibody production and spontaneous GC formation. IgG anti-
dsDNA autoantibody ELISAs in 6.5–12-mo-old female WASp+/, WASp/, and WT mice (A) and WT and WASp/ chimeras at 16 wk after transplant (B). 
BWF1: lupus-prone positive control, NZB/NZW-F1, 8 mo old. Sera diluted 1:200; each dot represents an individual animal. (C) ELISAs with low versus high 
stringency washing conditions used to detect high-affinity IgG anti-dsDNA antibodies in WASp/ and WASp/ chimeric mice (12 wk old or 12 wk after 
transplant). Each pair of bars represents an individual animal. (D–F) ELISAs to detect IgG subclass-specific anti-dsDNA antibodies. (WASp/ chimeras,  
n = 29; WASp/ mice, n = 10; 4 mo after transplant or 4 mo old, respectively). (G) Percentage of splenic B cells staining positive for PNA by flow cytometry 
in 6–8-mo-old WT (n = 7) and WASp/ (n = 7) mice, as well as WT (n = 5) and WASp/ (n = 4) BM chimeras 6–8 mo after transplant. (H) Immuno-
fluorescent staining of splenic sections from BM chimeras showing representative follicles using B220 (red) CD3 (blue) and PNA (green); 10× objective was 
used for image capture; bars, 100 µm. (I) Antigen microarray showing IgG reactivity of WT, WASp/, WT chimera, and WASp/ chimera sera with ssDNA, 
dsDNA, chromatin, and MDA-LDL. Sera from WT and WASp/ mice (1 yr) and chimeric mice (6 mo after transplant). Scale shows digital fluorescence 
intensity units; 600 represents threshold for reactivity as described in Materials and methods. These data are representative of 4 independent experiments 
with 20–30 mice per experiment. *, P < 0.05; **, P < 0.005; ***, P < 0.0005.2036 WASp-deficient B cells trigger autoimmunity | Becker-Herman et al.
which appeared to correlate with the intracapillary accu-
mulations  of  eosinophilic  material.  Immunofluorescent 
staining  demonstrated  deposition  of  IgG2b,  IgG2c,  and 
complement  C3  in  WASp/  chimera  glomeruli  (Fig.  2  D,   
II, IV, and VI), whereas less C3 deposition and little to no 
IgG2b and IgG2c deposition was detected in WT chimeras 
(Fig. 2 D, I, III, and V). However, there were no differences   
in deposition of IgG, IgA, and IgM. Glomerular thrombi ap-
peared moderately electron dense by electron microscopy 
(Fig. 2 E, left), and higher magnification analysis revealed 
focal regions of fibrillar organization, consistent with co-
deposited immune complexes (Fig. 2 E, right, arrows). Many 
of the thrombi had vacuoles of differing sizes that appeared 
to be lipid or lipoprotein accumulations (Fig. 2 E, arrow-
heads). In contrast, liver, lungs, joints, and gastrointestinal tract 
appeared  unaffected  in  WASp/  chimeras  (unpublished 
data). These results demonstrate that WASp/ chimeras 
develop systemic autoimmune disease characterized by gen-
eration of autoantibodies, severe renal histopathology, and 
early mortality.
WASp/ B cells are hyperresponsive 
to key activation signals in vitro  
and in vivo
We next sought to determine whether 
WASp/ B cells exhibit an altered re-
sponse to BCR engagement. WASp/ 
at 7 mo after transplant, with only 50% survival at 12 mo 
compared with 97% in WT recipients (Fig. 2 A).
To  better  characterize  disease  features,  we  monitored   
renal  function  and  performed  extensive  histopathological 
analyses in several cohorts. To screen for renal disease, we 
measured urine protein/creatinine ratio. WASp/ chimeras 
developed progressive proteinuria beginning 5–6 mo after trans-
plant (Fig. 2 B). Next, we analyzed the kidneys of WASp/ 
chimeras for histological abnormalities and identified wide-
spread glomerular lesions exhibiting prominent accumula-
tions of eosinophilic thrombuslike material within glomerular 
capillaries, as well as increases in mesangial matrix accumula-
tion, focal mesangiolysis, and glomerular basement mem-
brane splitting (Fig. 2 C, II). In contrast, WT chimeras were 
normal in appearance (Fig. 2 C, I). MAC-2 staining of kid-
ney sections revealed macrophage infiltration of glomeruli 
from WASp/, but not WT, chimeras (Fig. 2 C, III and IV). 
Notably, oil red O staining of frozen sections identified the 
presence  of  neutral  lipids  within  glomeruli  of  WASp/ 
chimeras, but not in WT chimeras (Fig. 2 C, V and VI), 
Figure 2.  WASp/ chimeras develop 
systemic autoimmunity and exhibit early 
mortality. (A) Kaplan-Meier survival curve of 
WT chimeras (n = 37) and WASp/ chimeras 
(n = 31). P < 0.0005. (B) Urine albumin/creati-
nine ratio in BM chimeras at 7–12 mo after 
transplant, WT chimeras (n = 22), and 
WASp/ chimeras (n = 26). *, P < 0.05.  
(C) Representative glomeruli from WT and 
WASp/ BM chimeras. PAS, Periodic acid-
Schiff stain. Bars, 50 µm. (D) Immunofluores-
cence showing IgG2b and IgG2c subclass 
antibodies and complement C3 deposited in 
WASp/ chimera glomeruli. Data in C and D 
are representative of mice 7 mo after trans-
plant. Bars, 50 µm. (E) Electron micrographs 
of glomeruli of WASp/ chimeras. Left: low 
power; 1600×; bar, 10 µm. Right: high power; 
16,900×; bar, 1 µm. The images show conflu-
ent deposition of large amounts of electron-
dense material (arrows) characteristic of 
immune complexes in subendothelial portions 
of glomerular capillary walls, admixed with 
aggregates of vesiculated material character-
istic of lipoproteins, corresponding to the lipid 
deposits confirmed by oil red O staining  
(arrowheads; representative of four WASp/ 
chimeras). Data are representative of four 
independent experiments; electron micro-
graphs taken from only one experiment.JEM Vol. 208, No. 10 
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prevented the glomerular pathology and IgG2b/c and C3 de-
position that were observed in untreated or isotype antibody–
treated WASp/ chimeras (Fig. 4 D). These data support our 
hypothesis that WT T cells in WASp/ chimeras drive CSR 
and affinity maturation of autoreactive WASp/ B cells, lead-
ing to production of pathological autoantibodies and systemic 
autoimmune disease.
B cell MyD88 signaling is required for autoimmunity  
in WASp/ BM chimeras
Because  we  observed  enhanced  proliferation  of  WASp/  
B cells in response to in vitro TLR engagement, we asked 
whether B cell–intrinsic TLR signaling is required for auto-
antibody  production  in  WASp/  BM  chimeras.  WASp/ 
MyD88/ double-deficient mice were generated and used 
as donors to generate cohorts of BM chimeras in which all   
B cells lacked both  WASp and MyD88, whereas all other hemato-
poietic lineages were WT-derived. WASp/MyD88/ chi-
meras did not produce IgG (or IgG subclass) anti-dsDNA 
antibodies (Fig. 4 A), demonstrated no increase in PNA+FAS+ 
B cells (Fig. 4 B), and did not develop spontaneous GC for-
mation on splenic sections (Fig. 4 C). In addition, WASp/ 
MyD88/ chimeras were completely protected from de-
veloping renal pathology and glomerular IgG2b/c and C3 
deposition (Fig. 4 D). These results indicate that B cell–intrinsic 
MyD88 signaling is essential for production of anti-dsDNA 
antibodies, GC formation, and development of systemic auto-
immune disease in WASp/ chimeras.
DISCUSSION
Autoimmunity is a hallmark of WAS, typically manifesting as 
humoral autoimmunity in up to 70% of WAS patients (Sullivan 
et al., 1994; Dupuis-Girod et al., 2003). Additionally, a large 
number of patients develop systemic autoimmunity after stem 
cell transplantation, and this complication strongly correlates 
with mixed chimerism (Ozsahin et al., 2008). Here, we dem-
onstrate  that  autoantibody  production  in  WASp/  mice 
does not result from a lack of T reg cell–mediated immuno-
suppression. We next addressed whether WASp/ B cells 
might trigger autoimmunity using mixed BM chimeras where 
only B cells lacked expression of WASp. Our data indicate 
that WASp/ B cells play a primary role in driving auto-
immunity; indicating that a single gene defect in B cells, yielding 
a modest increase in BCR and TLR signaling, is sufficient   
to  trigger  a  cell-intrinsic  loss  in  tolerance,  culminating  in 
pathogenic autoantibody production and lethal autoimmune 
disease in the setting of intact T cell function. We also show 
that B cell–intrinsic MyD88 signaling is essential for sponta-
neous GC formation, autoantibody production, and develop-
ment of renal pathology.
Consistent with a B cell–intrinsic model, we show for the 
first time that WASp/ B cells are modestly hyperresponsive 
to both anti-IgM and TLR stimulation, as measured by Ca2+ 
flux, proliferative responses, and modulation of activation mark-
ers. Additionally, we show that WASp/ B cells exhibit de-
creased BCR internalization, possibly accounting for at least 
splenic follicular mature (FM) B cells consistently exhibited a 
higher peak Ca2+ flux in comparison with WT FM B cells   
after BCR stimulation, a difference that was most pronounced 
when using lower dose anti-IgM (Fig. 3 A). IgM surface ex-
pression was equivalent or slightly lower in WASp/ B cells, 
indicating that altered BCR density could not account for 
our findings (Fig. 3 A). Experiments using Ca2+-free media 
and/or the Ca2+ ATPase-inhibitor thapsigargin indicated that 
WASp/ FM B cells exhibit enhanced extracellular Ca2+ in-
flux after BCR engagement (Fig. 3 D and Fig. S3 A).
Next, we evaluated proliferation downstream of BCR   
engagement by measuring CFSE dilution. We observed in-
creased proliferation in WASp/ FM B cells as compared 
with WT controls in response to anti-IgM stimulation (Fig. 3 B). 
Intriguingly, both LPS and CpG stimulation also lead to 
increased cell cycling (Fig. 3 B), indicating that hyperrespon-
siveness  was  not  limited  to  BCR  engagement.  WASp/  
B cells also displayed slightly increased CD25 and reduced 
CD62L expression compared with WT B cells, which is con-
sistent with a more activated state after stimulation (Fig. S3 B). 
To exclude the possibility that these observations were caused 
by altered lymphoid environments, we generated BM chime-
ras consisting of 50% Ly5.1+ WT and 50% Ly5.2+ WASp/ 
cells. Ca2+ flux and proliferation experiments using cells iso-
lated from transplanted mice led to findings that mirrored the 
aforementioned results (Fig. 3, D and E).
WASp plays an important role in cytoskeletal rearrange-
ment, leading us to hypothesize that a defect in BCR internaliza-
tion might explain the observed increase in AR responsiveness. 
Although down-regulation in BCR surface expression was 
detected in WASp/ B cells after BCR stimulation, this de-
crease was much less pronounced over the first 10 min com-
pared with WT cells (Fig. 3 C). Together, these data indicate 
that WASp/ B cells are hyper-responsive to BCR stimula-
tion, possibly because of decreased receptor internalization.
CD4 T cell depletion reduces autoantibody production  
and prevents disease in WASp/ chimeras
We hypothesized that the presence of WT T cells was critical 
for the formation of GCs and IgG2 subclass CSR, and for   
development of systemic autoimmune disease in WASp/ 
chimeras. To test this hypothesis, we treated a new cohort of 
WT and WASp/ chimeras weekly with monoclonal CD4-
depleting antibody (Fig. S4). Although WASp/ chimeras 
depleted of CD4 T cells still produced IgG anti-dsDNA anti-
bodies, albeit at lower levels than in untreated WASp/ chi-
meras, CD4 depletion completely prevented IgG2c anti-dsDNA 
production (Fig. 4 A). In contrast, IgG3 autoantibodies were 
not  eliminated  by  CD4  depletion  (Fig.  4 A).  In  addition,   
although lower in titer than untreated WASp/ chimeras, 
IgG2b autoantibodies were significantly higher in CD4-
depleted WASp/ chimeras than in WT chimeras (Fig. 4 A).   
As expected, WASp/ chimeras depleted of CD4 T cells did 
not exhibit an increase in GC phenotype (B220+PNA+FAS+) 
splenocytes (Fig. 4 B) and lacked spontaneous GC forma-
tion in splenic sections (Fig. 4 C). Finally, CD4 depletion 2038 WASp-deficient B cells trigger autoimmunity | Becker-Herman et al.
Figure 3.  WASp/ B cells are mildly hyper-responsive and display reduced BCR internalization. (A) Left and middle panel, Ca2+ flux in FM B cells stimu-
lated with 10 or 1 µg/ml anti-IgM. (right) sIgM expression in WT versus WASp/ FM B cells. Data are representative of 4 independent experiments (n = 8). (B) CFSE 
proliferation assay of sorted WT versus WASp/ FM B cells on day 3 after stimulation (1 = 1 µg/ml; 10 = 10 µg/ml). Data are representative of 3 experiments  
(n = 10). (C) BCR internalization assay. WT and WASp/ splenic B cells were incubated with biotinylated F(ab’)2 fragments to bind the BCR and chased for the 
indicated time points. Data are displayed as percentage of surface BCR relative to 0 time point. Data are representative of two independent experiments (n = 6 per 
experiment). (D and E) To assess the BCR signaling response in WT and WASp/ B cells derived from the same environment, BM from WT (Ly5.1+) and WASp/ 
(Ly5.2+) mice was mixed at a 50:50 ratio and transplanted into lethally irradiated MT recipient mice; recipients were sacrificed at 6–8 wk after transplant. (D) Ca2+ 
flux in stimulated FM B cells in the presence (top) or absence (bottom) of extracellular Ca2+ showing response in WT (Ly5.1+) versus WASp/ (Ly5.2+) gated FM 
populations stimulated with 10 µg/ml anti-IgM. (right) Relative sIgM expression in WT versus WASp/ FM B cells. (E) Proliferation of sort-purified, WT (Ly5.1+)  
versus WASp/ (Ly5.2+) FM B cells isolated from BM chimeras at day 3 after stimulation with the indicated mitogens. Data are representative of 2 independent 
experiments (n = 4 per experiment). FM B cells were sorted as CD19+CD24intCD21int cells, as previously described (Meyer-Bahlburg et al., 2008).JEM Vol. 208, No. 10 
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with our findings, autoimmune glomerulonephritis has also 
been described in WIP/ mice (Curcio et al., 2007).
Importantly, despite being intrinsically autoreactive, our 
data clearly show that WASp/ B cells alone are not suffi-
cient to initiate severe autoimmune disease. WASp/ mice de-
velop anti-dsDNA autoantibodies, but, in contrast to WASp/ 
chimeras, show minimal organ pathology and have normal 
lifespans. Strikingly, WASp/ mice primarily generated IgG3 
anti-dsDNA antibodies, as might be expected as a result of   
a T cell–independent process, whereas autoantibodies in 
WASp/ chimeras were comprised of IgG2 isotypes, previ-
ously shown to be associated with C3 deposition and nephritis 
in SLE animal models (Ehlers et al., 2006). This suggests that 
in  WASp/  mice,  WASp/ T  cells  provided  suboptimal 
cognate T cell help, an idea that is consistent with defective 
activation of WASp/ T cells in response to CD3 ligation   
or antigen-specific target cells (Bouma et al., 2009). In con-
trast,  WT  T  cells  present  in  WASp/  chimeras  appear   
to be essential to drive CSR and affinity maturation of patho-
genic autoantibodies. Consistent with this view, CD4 T cell 
depletion abrogated the generation of IgG2c anti-dsDNA anti-
bodies, despite intact production of IgG3 autoantibodies, 
a subset of these increased responses. Despite delayed BCR 
internalization, WASp/ mice do not have increased surface 
IgM levels on naive B cells. This may be because delayed inter-
nalization does not affect steady-state surface IgM levels,   
or, alternatively, WASp/ mice may have more autoreactive   
B cells in the preimmune repertoire, resulting in increased 
BCR engagement and subsequent down-regulation. Increased 
responsiveness to TLR ligands may also be caused by altered 
receptor processing, but this has not yet been tested. Contrary 
to our findings in B cells, multiple studies have shown de-
creased AR responsiveness in WASp/ T cells. Although the 
precise mechanisms remain to be determined, the opposing 
effect of WASp deficiency in B versus T cell AR signals likely 
reflects differing roles for the actin cytoskeleton in initiat-
ing and sustaining such responses. Notably, our findings are 
consistent with previous data in WASp-interacting protein 
(WIP)–deficient mice (Antón et al., 2002). Although WIP/ 
B cells exhibited increased proliferation and CD69 expression 
in response to BCR and TLR4 engagement, WIP/ T cells 
failed to proliferate or produce IL-2 after TCR stimulation; 
these findings are consistent with the role for WIP in stabiliz-
ing WASp expression (Ramesh and Geha, 2009). In concert 
Figure 4.  CD4 T cell depletion or B cell–intrinsic 
MyD88-deficiency prevents disease development 
in WASp/ chimeras. (A) ELISAs were used to 
measure dsDNA-specific total IgG, IgG3, IgG2b, and 
IgG2c serum antibodies (18 wk after transplant)  
in WASp/ chimeras, WASp/ chimeras treated weekly 
with CD4-depleting antibody (CD4 Depletion), and 
WASp/MyD88/ chimeras (WASp/MyD88/).  
Data are normalized to values obtained from  
WT chimera controls run alongside each experimental 
group, and significance tests demonstrate whether 
experimental values are statistically greater than 
control values for each ELISA. Dotted line is at nor-
malized value 1, representing autoantibody levels in 
WT chimeras. (B) Percentage of splenic PNA+ FAS+  
B cells in WT chimeras, WASp/ chimeras, CD4-
depleted WASp/ chimeras and WASp/MyD88/ 
chimeras (6 mo after transplant). (C) Immunofluores-
cent staining of splenic sections from WASp/  
chimeras (6 mo after transplant) to measure GC  
formation in WASp/ chimeras, CD4-depleted 
WASp/ chimeras, and WASp/MyD88/ chimeras. 
Representative follicles (10× objective) are shown 
using B220 (red), CD3 (blue), and PNA (green). Bars, 
100 µm. (D) Glomeruli of indicated chimeras were 
stained with the indicated reagents. PAS, Periodic 
acid-Schiff. Bars, 50 µm. *, P < 0.05; **P < 0.005;  
***, P < 0.0005. Isotype-treated WT and WASp/ 
chimeras showed no differences from untreated  
animals, respectively, and therefore data from isotype-
treated mice are not shown as a separate group. Data 
are representative of two independent experiments with 
WASp/MyD88/ chimeras (n = 30 and n = 15), and 
one independent CD4-depletion experiment (n = 24).2040 WASp-deficient B cells trigger autoimmunity | Becker-Herman et al.
B cells first impacts BCR specificities within the mature rep-
ertoire,  according  to  our  model,  DNA-reactive  WASp/  
naive B cells are initially activated by combined BCR and 
TLR engagement, to which WASp/ B cells are hyperre-
sponsive. In WASp/ chimeras, these activated, autoantigen-
specific B cells then recruit T cell help, leading to GC 
formation and production of high-affinity, class-switched auto-
antibodies. This idea is consistent with recent evidence from 
models using transgenic BCRs in autoimmune-prone mice, 
suggesting that B cells can play a primary role in initiating 
systemic autoimmunity through dual BCR/TLR activation 
(Herlands et al., 2008). Although not directly evaluated here, 
we predict that these combined events are exaggerated by,   
and may require, increased levels of BAFF in recipient MT 
mice; an idea that is consistent with the role for T cell– 
independent,  MyD88-dependent  generation  of  autoanti-
bodies in BAFF transgenic mice (Groom et al., 2007). Notably, 
elevated BAFF is also observed in WAS (and other immune-
deficient) patients undergoing stem cell transplantation, and 
may similarly amplify alterations in B cell tolerance in that 
setting (unpublished data). Ultimately, autoantibody-containing 
IgG2b/c immune complexes deposit in tissues such as kidney 
glomeruli, initiating end-organ pathology via their preferential 
binding to activating IgG Fc receptors (Nimmerjahn and   
Ravetch, 2005).
Our findings appear to provide a compelling mechanistic 
explanation for clinical observations wherein a large propor-
tion of WAS transplant recipients with mixed chimerism de-
velop severe, humoral autoimmunity, and suggest that these 
events should be considered in the design of future strategies 
for stem cell transplantation and viral-based gene replacement 
in WAS. Moreover, our data lend strong support to an emerg-
ing model (Shlomchik, 2009) whereby BCR/TLR-mediated 
activation of autoreactive B cells can function as the primary 
driver leading to subsequent break in T cell tolerance and sys-
temic autoimmunity.
MATERIALS AND METHODS
Mice. Ly.5.1+ and Ly5.2+ C57BL/6, µMT, WASp/ (F10 on a C57BL/6 
background), and MyD88/ mice were bred and maintained in the specific 
pathogen–free animal facility of Seattle Children’s Research Institute (Seattle, 
WA) and handled according to Institutional Animal Care and Use Committee 
approved protocols.
Reagents and antibodies. Anti-mouse antibodies used in this study in-
clude the following: CD24 (M1/69), CD21 (7G6), B220 (RA3-6B2), IgD 
(11-26C.2A), CD11 (9M1/70), IgDa (AMS 9.1), CD3e (145 2C11), and 
CD4(RM4-5) (all from BD); BP1 (FG35.4), CD25 (PC61), CD62L (MEC-14), 
CD11c (N418), Gr-1 (RB6-8C5), and Foxp3 (FJK-16S) (all from EMD Bio-
science); CD23 (B3B4) (Invitrogen); IgM (1B4B1), Kappa (187.1), Lambda 
(JC5-1), goat anti–mouse IgG-, IgG2b-, IgG2c-, IgG3-HRP conjugated and 
SA-HRP conjugated (from SouthernBiotech); CD19 (ID3), NK.1 (PK136), 
IgMa (DS-1), CD8a (53–6.7) (from BioLegend); and Cy5 anti–rabbit polyclonal 
IgG (Jackson ImmunoResearch Laboratories). Purified polyclonal rabbit anti-
WASp was provided by Dr. Hans Ochs (University of Washington, Seattle).
Flow cytometry and cell sorting. As previously described (Meyer- 
Bahlburg et al., 2008a,b), single-cell suspensions from BM, peripheral blood,   
and spleen were incubated with fluorescently labeled antibodies, and data were 
and  prevented  formation  of  renal  pathology.  However, 
WASp/ chimeras depleted of CD4 T cells still produced 
IgG2b anti-dsDNA antibodies, although at lower levels than 
in WASp/ chimeras treated with isotype antibodies, indi-
cating T cell–independent activation. In addition, CSR can 
explain some of the IgG2b autoantibodies in WASp/ chi-
meras. The  presence  of  IgG2b  subclass  autoantibodies  in 
CD4-depleted  chimeras,  but  not  WASp/  mice,  suggests 
that hematopoietic cells other than CD4 T cells may provide 
activating signals that contribute to CSR, dependent on the 
expression of WASp. WASp/ DCs have an impaired ability 
to prime T cells (Bouma et al., 2007), and may also lack the 
ability of WT DCs to promote B cell activation, possibly via 
impaired antigen presentation or secretion of soluble factors.
TLR signaling and MyD88 play a prominent role in B cell 
activation in various autoimmune models (Marshak-Rothstein 
and Rifkin, 2007), and DNA-specific B cells are capable of 
activation and antibody production in vitro after only BCR 
and TLR engagement (Viglianti et al., 2003; Fields et al., 
2006). Therefore, we evaluated the contribution of TLR sig-
naling in our model by generating chimeras lacking both 
WASp and MyD88 only in the B cell compartment. Defi-
ciency  of  MyD88  prevented  development  of  IgG  anti- 
dsDNA antibodies, spontaneous GCs, and renal pathology, 
confirming its importance in the autoimmune disease ob-
served in WASp/ chimeras. In another study (Barr et al., 
2009), antigen-specific IgG2c, but not IgG2b, IgG3, or IgG1, 
in response to T cell–dependent antigen immunization was 
shown to completely depend on B cell MyD88 signaling, 
possibly because of the failure of MyD88-deficient B cells to 
activate IFN-–producing effector T cells. In our model, the 
lack of any IgG DNA-specific antibodies in the absence of   
B cell MyD88 signals suggests that initial activation of DNA-
specific B cells requires simultaneous BCR and TLR engage-
ment,  perhaps  by  cell  death–derived  nuclear  autoantigens. 
Experiments  are  underway  to  determine  whether  specific 
TLRs, such as TLR9, are responsible for the effect of MyD88 
deficiency.  Additionally,  based  upon  the  requirement  for 
MyD88 in TACI-dependent CSR, it will be of interest to de-
termine the potential role for TACI engagement by BAFF or 
APRIL in this process (He et al., 2010).
In summary, we provide insight into the pathogenesis of 
autoimmunity  in  WASp/  mice,  suggesting  that  hyper-
responsive B cells play a primary role in initiating loss of toler-
ance and producing anti-DNA autoantibodies. Several mouse 
models have been described in which alterations in B cell sig-
naling molecules contribute to development of autoimmune 
disease  (Cornall  et  al.,  1998;  Bolland  and  Ravetch,  2000; 
Grimaldi et al., 2005). In mice lacking the inhibitory receptor 
FcRIIB, development of autoimmunity also appears to be   
B cell intrinsic and MyD88/TLR9 dependent (Ehlers et al., 
2006). Recent data on this model suggests this is primarily 
caused by failure of GC cell negative selection, and not a   
defect in selection of the preimmune repertoire (Tiller et al., 
2010).  Although  further  experimentation  is  required  to   
define  how  increased  antigen  responsiveness  in  WASp/  JEM Vol. 208, No. 10 
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Antigen microarrays. Microarray studies were performed with nitro-
cellulose-coated slides, as previously described (Silverman et al., 2008). 
Background correction used a MATLAB script, and the mean values for 
replicate spots were determined with JMP 7.0 software. Cluster analysis dia-
grams from comparisons of replicate arrays, after processing with monoclo-
nal IgM or sera, were generated with Cluster 3.0 (Stanford University) and 
Java TreeView  (rana.lbl.gov/EisenSoftware.htm).  Background  levels  were 
confirmed based on replicate slides developed without sera. In these studies, 
a level of 600 digital fluorescence intensity units was set as a threshold for 
significant reactivity, which was the mean background ±3 SD.
T cell depletion. Mice were treated weekly with i.p. injection of 250 µg 
anti-CD4 (GK1.5) or isotype control (rat IgG2b) antibody (UCSF Antibody 
Core) beginning 5 wk after transplant.
Statistical  evaluation. P-values were calculated using the two-tailed   
Student’s t test. For analysis of survival, Kaplan-Meier analyses were used.
Online supplemental material. Fig. S1 shows functional analysis of WASp+/ 
T reg cells and relative chimerism of splenic populations in BM chimeras. 
Fig. S2 shows ELISAs testing MDA-LDL reactivity of sera samples. Fig. S3 
further explores the hyperresponsiveness in WASp/ B cells. Fig. S4 demon-
strates efficacy of long-term CD4 depletion. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20110200/DC1.
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